Latest Cancer treatments Stories
OAKLAND, Calif., June 27, 2014 /PRNewswire/ -- When friends asked Warren Keppler what he wanted out of fatherhood back in 2004, his answer came naturally: "I want to run with my girls."
Immunitor Inc., reported that company’s first proof-of-concept clinical study of its candidate cancer vaccine in patients with terminal stage of liver cancer has been presented at the immunology
LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Using CyberKnife and chemotherapy, doctors treat primary and metastatic tumors FENTON, Mo., June 24, 2014 /PRNewswire/ -- When St.
SAN ANTONIO, June 23, 2014 /PRNewswire/ -- GenSpera, Inc.
BUSAN, South Korea and SAN FRANCISCO, June 20, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company focused on the development of targeted oncolytic immunotherapy products
Merger Creates Global Leader In Oncolytic Immunotherapy BUSAN, South Korea and SAN FRANCISCO, June 19, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival.
Unique Immuno-Oncolytic Therapy Gets Closer to a More Effective, Safer Cancer Treatment and Potential Cure CLEVELAND, June 18, 2014 /PRNewswire-USNewswire/ -- Western Oncolytics
SCHAUMBURG, Ill., June 10, 2014 /PRNewswire-USNewswire/ -- Extensive clinical experience suggests that hyperthermic intraperitoneal chemotherapy (HIPEC) may play an important role in the ongoing
More Images (3 images) »